AU2002344204A1 - Monovalent salt enhances solubility of milk protein concentrate - Google Patents
Monovalent salt enhances solubility of milk protein concentrateInfo
- Publication number
- AU2002344204A1 AU2002344204A1 AU2002344204A AU2002344204A AU2002344204A1 AU 2002344204 A1 AU2002344204 A1 AU 2002344204A1 AU 2002344204 A AU2002344204 A AU 2002344204A AU 2002344204 A AU2002344204 A AU 2002344204A AU 2002344204 A1 AU2002344204 A1 AU 2002344204A1
- Authority
- AU
- Australia
- Prior art keywords
- mpc
- mpi
- solubility
- dried
- protein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000003839 salts Chemical class 0.000 title claims description 44
- 108010011756 Milk Proteins Proteins 0.000 title claims description 22
- 102000014171 Milk Proteins Human genes 0.000 title claims description 22
- 235000021239 milk protein Nutrition 0.000 title claims description 20
- 239000012141 concentrate Substances 0.000 title description 7
- 150000001768 cations Chemical class 0.000 claims description 45
- 238000000034 method Methods 0.000 claims description 34
- 235000018102 proteins Nutrition 0.000 claims description 34
- 102000004169 proteins and genes Human genes 0.000 claims description 34
- 108090000623 proteins and genes Proteins 0.000 claims description 34
- 238000001035 drying Methods 0.000 claims description 23
- 235000013351 cheese Nutrition 0.000 claims description 19
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 19
- 235000020183 skimmed milk Nutrition 0.000 claims description 16
- 239000000243 solution Substances 0.000 claims description 14
- 235000013336 milk Nutrition 0.000 claims description 13
- 210000004080 milk Anatomy 0.000 claims description 13
- 238000004519 manufacturing process Methods 0.000 claims description 12
- 239000008267 milk Substances 0.000 claims description 11
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical group [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 10
- 239000007864 aqueous solution Substances 0.000 claims description 10
- 239000007900 aqueous suspension Substances 0.000 claims description 9
- 238000011026 diafiltration Methods 0.000 claims description 9
- 239000011591 potassium Substances 0.000 claims description 9
- 229910052700 potassium Inorganic materials 0.000 claims description 9
- 238000000108 ultra-filtration Methods 0.000 claims description 7
- 238000001704 evaporation Methods 0.000 claims description 6
- 230000008020 evaporation Effects 0.000 claims description 6
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical group [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 5
- 239000011780 sodium chloride Substances 0.000 claims description 5
- 239000007858 starting material Substances 0.000 claims description 5
- 159000000007 calcium salts Chemical group 0.000 claims description 2
- 159000000000 sodium salts Chemical class 0.000 claims description 2
- 239000000725 suspension Substances 0.000 claims 1
- 239000000843 powder Substances 0.000 description 70
- 239000000523 sample Substances 0.000 description 35
- 238000003860 storage Methods 0.000 description 28
- 239000000047 product Substances 0.000 description 23
- 239000011734 sodium Substances 0.000 description 21
- 229910052708 sodium Inorganic materials 0.000 description 21
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 19
- 230000000694 effects Effects 0.000 description 15
- 239000012465 retentate Substances 0.000 description 14
- 230000001965 increasing effect Effects 0.000 description 9
- 238000002360 preparation method Methods 0.000 description 8
- -1 sodium cations Chemical class 0.000 description 7
- 230000015572 biosynthetic process Effects 0.000 description 5
- 239000007787 solid Substances 0.000 description 5
- 101100238326 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) SPO21 gene Proteins 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 108010046377 Whey Proteins Proteins 0.000 description 3
- 239000012267 brine Substances 0.000 description 3
- 239000005018 casein Substances 0.000 description 3
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 3
- 235000021240 caseins Nutrition 0.000 description 3
- 150000003841 chloride salts Chemical class 0.000 description 3
- 229910001415 sodium ion Inorganic materials 0.000 description 3
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 3
- 235000021119 whey protein Nutrition 0.000 description 3
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- 239000008364 bulk solution Substances 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 239000002738 chelating agent Substances 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000008367 deionised water Substances 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 230000020477 pH reduction Effects 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 229940108461 rennet Drugs 0.000 description 2
- 108010058314 rennet Proteins 0.000 description 2
- 239000013049 sediment Substances 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 239000008186 active pharmaceutical agent Substances 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 238000005341 cation exchange Methods 0.000 description 1
- 230000009920 chelation Effects 0.000 description 1
- 239000013068 control sample Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 230000001627 detrimental effect Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 238000000635 electron micrograph Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 239000011552 falling film Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 238000007667 floating Methods 0.000 description 1
- 239000011888 foil Substances 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 238000001471 micro-filtration Methods 0.000 description 1
- 239000011785 micronutrient Substances 0.000 description 1
- 235000013369 micronutrients Nutrition 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 159000000001 potassium salts Chemical class 0.000 description 1
- 235000008476 powdered milk Nutrition 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 235000019624 protein content Nutrition 0.000 description 1
- 238000005086 pumping Methods 0.000 description 1
- 235000020122 reconstituted milk Nutrition 0.000 description 1
- 239000012266 salt solution Substances 0.000 description 1
- 238000009938 salting Methods 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 238000004627 transmission electron microscopy Methods 0.000 description 1
- 238000013060 ultrafiltration and diafiltration Methods 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
Description
Monovalent Salt Enhances Solubility of Milk Protein Concentrate
TECHNICAL FIELD
5 This invention relates to milk products, processes for their preparation and use, particularly in cheese manufacture.
BACKGROUND ART
10 A "milk protein concentrate" (MPC) is a milk protein product in which greater than 55%, preferably greater than 75%, of the dry matter is milk protein and the ratio of casein to whey proteins is approximately that of milk. Such concentrates are known in the art. MPCs are frequently described with the % dry matter as milk protein being appended to "MPC". For example MPC70 is an MPC with 70% of the dry matter as milk protein.
•15
The- term "milk protein isolate" (MPI) refers to a milk protein composition comprising a substantially unaltered proportion of casein to whey proteins wherein the dry matter consists of greater than 85% milk protein. Such isolates are known in the art.
20 These products differ from milk concentrates in that they are high in protein and low in fat and lactose. They differ from skim milk concentrates in that they are high in protein and low in lactose.
One use for MPC and MPI is in cheese manufacture. By addition of these to increase the protein 25 concentration of milk used in the manufacture of cheese, cheese making can be made more consistent and more efficient.
Using evaporation and drying, it is possible to obtain dried MPC and MPI. The key problem in manufacturing a dried high protein milk protein concentrate is that such products are generally 30 very insoluble at cold temperatures. This is particularly a problem where the milk protein content is 85% or more. However even at milk protein contents as low at 70% it is also a problem. In addition the solubility at all temperatures declines on storage.
Also these dried products suffer from the disadvantage that they are associated with the formation of nuggets in the cheese. Nuggets are thin protein gels of a different colour in the cheese. Nugget formation is consistently a problem when dried MPI with 85% dry matter as milk protein is used.
Nugget formation occurs on some but not all occasions when a dried MPC with 70% dry matter as milk protein is used. These problems can be overcome by use of elevated temperatures after mixing the dried MPC or MPI with the milk. However, this adds an extra step to the cheese manufacturing process.
WO 01/41578 describes methods for preparing dried MPC or MPI using calcium removal by one of (1) use of a cation exchanger (2) acidification and dialysis and (3) chelation. However a need for a simple method for preparing dried MPC and MPI with good solubility properties remains as these methods involve either extra processing steps or addition of chelating agents.
An object of the present invention is to provide an improved method for preparing a dried milk protein product with enhanced solubility properties and/or a reduced tendency to cause nugget formation in cheesemaking without the need for use of cation exchange, acidification or addition of chelation agents, or at least to provide the public with a useful choice..
DISCLOSURE OF THE INVENTION
In one aspect, the invention provides a method for preparing a dried enhanced-solubility MPC or MPI product comprising:
(a) providing an MPI or MPC having at least 70% dry matter as milk protein in aqueous solution/suspension;
(b) adding at least one monovalent salt in an amount that confers enhanced solubility on the product when dried; and
(c) drying the product.
Preferably between salt addition and drying steps, this process and other processes of the invention include a dewatering step, preferably using evaporation.
The term "enhanced-solubility" refers to the property of a product which on reconstitution into a
5% w/v solution provides less sediment on centrifugation for 10 minutes at 700g relative to the corresponding product without salt treatment. For example the enhanced-solubility may be solubility at 20°C where there is less than 5% sediment on centrifugation at 10 minutes at 700g.
Additionally or alternatively the enhanced solubility may be demonstrable at a range of temperatures below 60°C. In some cases the enhanced solubility will be enhanced solubility following storage. That particular property may not be readily measurable immediately after manufacture but becomes apparent subsequently.
In another aspect the monovalent or divalent salt is added directly to the skim milk used to prepare the MPI or MPC. Thus the invention provides a method for preparing a dried enhanced- solubility MPC or MPI product comprising:
(a) providing a skim milk in the form of an aqueous solution/suspension;
(b) adding at least one monovalent salt;
(c) concentrating the solution obtained by ultrafiltration, optionally with diafiltration to form an MPI or MPC having at least 70% dry weight as protein and
(d) drying to prepare a dried product with enhanced solubility.
In the process of this aspect of the invention, the amount of salt used is greater to allow for loss during ultrafiltration and any diafiltration. This may be calculated so that the ratio of added salt to protein at the time of drying is equivalent to that in the first aspect of the invention at the same stage.
In a further aspect the monovalent salt is added during diafiltration. Thus there is provided a method of preparing a dried enhanced-solubility MPC or MPI comprising:
(a) providing a skim milk solution in the form of an aqueous solution/suspension;
(b) concentrating the skim milk by ultrafiltration, with diafiltration, to form an MPI or MPC having at least 70% dried weight as protein;
(c) drying to prepare a dried product with enhanced solubility;
wherein the diafiltration medium comprises at least one monovalent salt. Again, the ratio of added salt to protein at the time of drying may be calculated to be the same to that in the first aspect of the invention.
In a further aspect, the monovalent salt is added to the MPC or MPI during or after a dewatering step which reduces the water content of the MPI or MPC, but does not dry the product. Thus there is provided a method for preparing a dried enhanced-solubility MPC or MPI comprising: (a) providing an MPI or MPC having at least 70% dry matter as milk protein in aqueous solution/suspension;
(b) removing part of the water from the MPC or MPI;
(c) adding to the concentrated MPC or MPI at least monovalent salt in an amount that confers solubility on the product;
(d) drying the product.
In a preferred embodiment the dewatering step is an evaporation step.
Common to each of the above aspects of the invention is the addition of an edible monovalent salt. Preferred salts are sodium and potassium salts, preferably chlorides. Sodium salts are currently preferred, especially sodium chloride. Divalent salts may be added additionally, including calcium salts. Salts which may be used include Mg, Fe and Zn salts.
The MPC or MPI may be prepared by conventional methods using ultrafiltration optionally with diafiltration. The dewatering and drying steps may also be those conventionally used.
The starting material is preferably freshly prepared MPI or MPC in aqueous solution/suspension as opposed to being reconstituted and dried. However it is also possible to reconstitute MPC or MPI with poor reconstitution properties and use the method of the invention to improve its properties. Because of the poor reconstitution properties, reconstitution is carried out at temperature sufficient to solubihse it, for example 50°C. However following processing according to the invention improved solubility at lower temperature can be obtained.
By manipulating the choice of sodium or potassium, or the pH of the retentate post ultrafiltration and diafiltration, it is possible to vary the flavour of the product. Typically the pH used would be in the range 6.2-7.0. For some circumstances it will also be useful to provide micronutrient cations in addition to sodium or potassium.
The drying techniques used in the invention include thermal falling film evaporation and spray drying. Drying may be proceeded by dewatering.
The term "skim milk" includes skim milks which have undergone some pretreatment which does not substantially alter the proportions of casein to whey proteins.
An example of such a pretreatment would include for example a pH treatment or an ionic exchange treatment. However, skim milk, particularly freshly prepared skim milk, is a preferred starting material.
It is noted that the term "addition of a monovalent or divalent salt" includes methods of increasing the salt content indirectly, for example by addition of a base such as sodium hydroxide or potassium hydroxide following addition of a buffer, not itself composed of mono and divalent salts.
The amount of monovalent salt to be added is generally an amount which will provide an increase in the cation to protein ratio of 0.013-0.30 moles per lOOg protein, preferably 0.035-0.25 moles per lOOg protein, most preferably 0.035-0.10 moles per lOOg protein. For divalent salts the amount to be added is lower - 0.004-0.15 moles per 1 OOg protein, preferably 0.006-0.08 moles per 1 OOg protein.
The solubility properties of the products of the process of the invention make the resulting dried MPC and MPI advantageous in the preparation of a variety of products. For example the increased solubility allows for more ease of use in incorporation into beverages. Also, the dried MPC and MPI of the invention may be advantageously used in cheese manufacture for avoidance of nugget formation.
It is noted that by changing the drying conditions one can make considerable changes to the solubility of the dried powder. In general a higher outlet temperature results in a decrease in solubility and a reduction in functional properties of the dried powder. It is recognised that through manipulation of the drying conditions one can enhance or reduce the effect that salt addition has on the functional properties of the powder produced.
BRIEF DESCRIPTION OF DRAWINGS
Figure 1 is a graph of cold water solubility of reconstituted MPC 85 manufactured with and without added sodium ions at a range of hydration times (with and without storage at 40°C for 7 days).
•Fresh, added sodium; OFresh, no added sodium; AStored, added sodium; Δ Stored, no added sodium
Figure 2 is a graph of solubility of the MPC (over a range of reconstitution temperatures) manufactured in the larger scale trial with and without added sodium ions at a range of temperatures.
OFresh ,added sodium; •Fresh, no added sodium;
DStored at 40°C for 7 days, added sodium; ■Stored at 40°C for 7 days, no added sodium;
Δ Stored at 40°C for 1 month, added sodium; AStored at 40°C for 1 month, no added sodium; O Control powder stored at 40°C for 7 days and reconstituted in salt water
Figure 3 shows electron micrographs of control and cation-enhanced MPC85 powders (0.045 mol sodium/1 OOg protein) manufactured on a commercial plant that have been stored at 40°C for differing lengths of time.
Figure 4 shows the effect of storage at 40°C on solubility of MPC85 powders with increasing concentrations of added cation (• - sample E (control); ■ - sample F (0.06 moles/1 OOg protein); A - sample G (0.10 moles/lOOg protein)) reconstituted in water at 20°C.
Figure 5 shows the effect of storage at 40°C on solubility of MPC85 powders with increasing concentrations of added cation (• - sample E (control); ■ - sample F (0.06 moles/1 OOg protein); ▲ - sample G (0.10 moles/1 OOg protein)) reconstituted in water at 30°C.
Figure 6 shows the effect of storage at 40°C on solubility of MPC85 powders with increasing concentrations of added cation (• - sample E (control); ■ - sample F (0.06 moles/1 OOg protein); A - sample G (0.10 moles/1 OOg protein)) reconstituted in water at 40°C.
Figure 7 shows the effect of storage at 40°C on solubility of MPC70 powders with increasing concentrations of added cation (• - sample J (control); ■ - sample I (0.06 moles/1 OOg protein); A - sample J (0.11 moles/ 1 OOg protein)) reconstituted in water at 20°C.
Figure 8 shows the effect of storage at 40°C (closed symbols fresh; open symbols 2 weeks storage) on solubility of MPC85 powders with (• - sample K) and without (■ - sample E) added sodium cations (0.030 moles/lOOg protein) reconstituted in water over a range of temperatures. Figure 9 shows the effect of storage at 40°C (closed symbols fresh; open symbols 2 weeks storage) on solubility of MPC85 powders with (• - sample L) and without (■ - sample E) added potassium cations (0.030 moles/1 OOg protein) reconstituted in water over a range of temperatures.
Figure 10 shows the effect of storage at 40°C (closed symbols fresh; open symbols 2 weeks storage) on solubility of MPC85 powders with (• - sample M) and without (■ - sample E) added potassium cations (0.023 moles/1 OOg protein) reconstituted in water over a range of temperatures.
Figure 11 shows the effect of storage at 40°C (closed symbols fresh; open symbols 2 weeks storage) on solubility of MPC85 powders with (• - sample N) and without (■ - sample A) a mixture of added potassium cations (0.031 moles/lOOg protein) and calcium cations (0.006 moles/1 OOg protein) reconstituted in water over a range of temperatures.
Figure 12 shows the solubility/powder storage profiles of a commercial MPC85 powder (A) and the same commercial MPC85 powder that has been reconstituted at 50°C, had sodium and potassium cations added (total cation addition of 0.221 moles per lOOg) and then redried (•) (Sample O - Table 1).
Figure 13 is a schematic diagram of cation enhanced MPC manufacture.
EXAMPLES
The following examples further illustrate practice of the invention. Table 1 shows the amount of added cation for samples A-O described in the Examples.
Table 1 The added cation composition of the experimental MPC powders described in the Examples.
EXAMPLE 1 - Small Scale Demonstration of Process
An MPC retentate is produced when skim milk is subj ected to concentration on an ultrafiltration (or a microfiltration) membrane (Koch S4 HFK 131 type membranes having a nominal molecular cut-off of 10,000 daltons) to produce an MPC retentate. Depending on the concentration factor used, the MPC retentate will have a protein content in the range of 42 to 85% of the dry matter as milk protein.
Commercially manufactured MPC85 retentate (20% w/w total solids) from Anchor Products Hautapu New Zealand was obtained and split into two batches of 5 litres.
To one batch sodium ions, in the form of its chloride salt, were added to the retentate at the same proteimsodium ratio as found in skim milk (0.05 moles sodium/1 OOg protein). 30.9 lg of NaCl dissolved in 100ml of deionised water was added to 5 litres of retentate and mixed at 40°C for 90 minutes.
The second batch was used as a control. To the control batch (5 litres of retentate) 100ml of deionised water was added and mixed at 40°C for 90 minutes.
Both batches of retentate were dried on a laboratory spray drier. The drier operating parameters were: inlet air temperature 1 0°, outlet air temperature 90°C.
The cold water solubility of the powder was determined at 20°C. A 5% w/w solution for each was prepared in cold water (20°C). Samples were extracted 30, 60, 120, 280 and 455 minutes of reconstitution and spun in a centrifuge at 700g for 10 minutes. The total solids content of the supernatant from each sample was compared to the total solids of the bulk solution to give a percent solubility. This data was plotted to give the cold water solubility profile shown in Figure 1. The cation-enhanced product (sample A - Table 1) was more soluble than the control (sample B - Table 1). The effect was more pronounced after storage for 7 days at 40°C (see Figure 1).
EXAMPLE 2 - Larger Scale Demonstration of the Process
A larger scale trial was conducted to manufacture 60 kg of MPC85 powder with an added salt (NaCl) to give a final added sodium concentration in the powder of 0.045 mol/lOOg protein (sample C -Table 1) and 60 kg of control MPC85 with no salt addition (sample D - Table 1).
The trial was performed by pumping a brine solution (20% w/w NaCl) into MPC85 retentate prior to evaporation and drying. The addition of the brine solution diluted the retentate by about 0.5%. The brine solution had a contact time with the retentate in the pipe-work prior to the evaporator of about 5-10 minutes.
The powders were stored at 40°C in sealed foil sachets. 40°C is a temperature that powder can typically reach during transportation, particularly in the holds of ships and on wharves and in warehouses in warm climates. Deterioration reactions in powders happen at a faster rate at 40°C than at lower temperatures. Time-scales for differences in powders at lower temperatures such as 20°C will likely be an order of magnitude longer. According to Labuza (in An integrated approach to food chemistry: Illustrative cases. InFood Chemistry, Fenema, O. (ed). Pp 913-938, (1985)) a shelf life of 1 month at 40°C can be equivalent to 18 months shelf life at 23°C for dehydrated foods.
The temperature solubility profiles were obtained by mixing samples of the powders in water for 30 minutes at a range of temperatures and then centrifuging at 700g for 10 minutes. The
solubility was determined by comparison of the supernatant total solids with the bulk solution total solids as in Example 1.
The solubility profile of the powders made on large scale were somewhat different from the powders made on pilot plant scale and small scale. This difference is probably due to the use of different driers. No difference in solubility was detected between the solubility/temperature profiles of the fresh powder with added salt and the fresh control powder with no added salt.
A difference was observed after the powders have been stored at 40°C for 7 days with the cation- enhanced powder sho ing significant improvement in solubility compared to the control powder. The results are shown in Figure 2.
After storing the powder at 40°C for one month the difference is even more dramatic. For example at a reconstitution temperature of 50°C the cation-enhanced powder has a solubility of 95% whereas the control powder has a solubility of less than 46%.
The transmission electron microscopy images shown in Figure 3 also demonstrate the stability of the cation-enhanced powders. One can clearly see that the protein (stained black in the images) in the control powder changes on storage at 40°C whereas the morphology of the cation-enhanced powder remains constant. The implication of these images is that the protein in the cation- enhanced powders maintains its functional properties for longer than standard high protein powders.
The improved solubility on storage (even at large scale) will enable more consistent product to reach customers and affords the powder with more robustness with regard to temperature abuse during shipping and storage prior to use.
EXAMPLE 3 - Addition of Cations - Cations After the Drying Process
This experiment was carried out to determine if the improved solubility in the stored powder of Example 2 could be duplicated simply by adding salt to dried MPC85. A lOg sample of the stored (7 days at 40°C) control powder (sample D - Table 1) was dissolved in a 190g solution (30°C) containing the same amount of dissolved salt (0.2288g) that would be added if lOg of cation-enhanced powder were being dissolved. The composition of this control solution with added salt was therefore no different to a solution of cation-enhanced powder. The solubility of the stored control sample was no different dissolved in a salt solution (53.34% w/w) than it was
dissolved in pure water (53.68% w/w). This experiment shows that surprisingly the addition of salt prior to drying is necessary to confer improved solubility.
EXAMPLE 4 - Effect Increasing Cation Concentration The experiments manufacturing MPC85 with added cations (refer Samples E,F and G - Table 1) show that the effect of cation addition is more pronounced with increasing cation concentration (figures 4 to 6). At low cation concentration the effect on solubility in fresh powder is minimal but on storage these powders exhibit enhanced solubility, particularly at high temperatures. Powders with higher cation concentrations exhibit enhance solubility even in fresh powder and at low temperatures.
EXAMPLE 5 Cation - enhancement for MPC70
In this experiment sodium cations were added at two different levels to MPC70 retentate prior to drying (samples I and J - Table 1). A control powder (sample H- Table 1) with no added cations was also made with the same batch of retentate. The solubility at 20°C/storage stability profiles for these powders are shown in figure 7. As with cation addition to MPC85, the effect on solubility increases with storage time and with increasing cation concentration.
EXAMPLE 6 - Comparison of Different Monovalent species The positive effect of cation addition on enhancing the solubility of MPC is shown by comparison of the solubility storage figures (figures 8 to 10) for sodium-enhanced (Table 1 - sample K) and potassium-enhanced (Table 1 - samples L and M) powders which have been made with the same molar addition of cation and the same mass of salt added per lOOg protein - respectively. These figures show that different species of monovalent cations have very similar effects on the solubility/storage properties of MPC powders.
EXAMPLE 7 - Divalent Cation Addition
The solubility/storage profile (Figure 11) for powder N (refer Table 1) shows that with the technology described here it is possible to add divalent cations, in combination with a monovalent cation, with no detrimental effect in the solubility of fresh powder reconstituted in water between 20 to 40°C. On storage at 40°C the divalent enhanced powder shows improved solubility characteristics, when reconstituted at 40°C, over the control powder. The improved solubility characteristics were not seen at reconstitution temperatures of 20°C nor 30°C.
EXAMPLE 8 - Conversion of poor powder to good powder
In this example a commercial MPC85 powder was reconstituted at 50°C, had sodium (0.081 moles/lOOg protein) and potassium (0.14 moles/lOOg protein) ions added (in the form of their chloride salts) and then re-dried to give a cation-enhanced powder (sample O in Table 1). Figure 12 shows that compared to the base starting powder, the cation-enhanced powder was converted to an MPC powder with a significantly improved cold (20°C) solubility profile. The solubility of the converted powder is 88% fresh and 87% after 7 days storage at40°C compared to 46 and 35% solubility for the original powder respectively.
This example shows that application of the technology described here can convert old stock with poor solubility properties into powder with excellent solubility.
EXAMPLE 9 - Cheese milk extension
Four MPC samples with 85% milk protein were tested in cheese making. 3.47kg of fresh skim milk containing 4.38% protein and 0.18% fat was the starting material. Fresh cream (505grams) containing 2.06% protein and41.2% fat was added undermedium shear to the fresh skim milk previously brought to 32.5°C. The resulting milk solution contained 4.07% protein and 5.36% fat as determined by Milkoscan Analyses.
The milk solution was divided into four batches. To each batch a different MPC containing 85% protein was added. One batch received the fresh large scale control MPC85 (sample D - Table 1), a second received a large scale control MPC85 (sample D - Table 1 ) that had been stored at 40°C for 7 days. The third batch received the fresh large scale cation enhanced MPC85 (sample C - Table 1) and the fourth batch received large scale cation enhanced MPC85 (sample C - Table 1) stored at 40°C for 7 days. The reconstitution was carried out at 4.5 to 8.5°C.
All powders dispersed into the milk well. No problems were noticed with the powders lumping, not wetting or floating on top of the milk. The pH of all the reconstituted milks were similar with the pH between 6.5 to 6.6 when measured at 32.5°C.
•Cheese manufacture was by a standard cheddar process. The rennet used was Australian DS.
After two days the cheese preparations were examined. In the two cheese preparations to which control MPC85 (fresh and stored at 40°C) many large grey translucent nuggets were obvious. The nuggets in the cheese preparation made from control MPC85 that had been stored at 40°C for 7 days were larger and more numerous than those present in the cheese preparation made from the
fresh control MPC85. The cheese preparations made from the cation-enhanced MPC85 both contained only a few very small strands of nugget material.
Observations made during- the cheese making steps showed that the starters performed excellently in all the re-constituted milks and that the pH of all the milks dropped to 6.45 to 6.46 over the 15 minute incubation period. All the preparations formed a coagulum at 40minutes after rennet was added. For all four samples the cooked curd character was excellent. None of the curds presented any problems during the salting and pressing steps.
When used for cheese extension applications the cation-enhanced MPC was judged to be a significant improvement, particularly when comparing the powders stored at 40 °C for 7 days, over the control MPC85.
The above examples are illustrations of the practice of the invention. It will be appreciated by those skilled in the art that the invention can be carried out with numerous modifications and variations. For example, the material subjected to the process can show variations in protein concentration and pH, and the timing of salt addition and drying procedures can be varied.
Claims (16)
1. A method for preparing a dried enhanced-solubility MPC or MPI product comprising:
(a) providing an MPI or MPC having at least 70% dry matter as milk protein in aqueous solution suspension;
(b) adding at least one monovalent salt in an amount that confers enhanced solubility on the product when dried; and
(c) drying the product.
2. A method for preparing a dried enhanced-solubility MPC or MPI product comprising:
(a) providing a skim milk in the form of an aqueous solution/suspension;
(b) adding at least one monovalent salt;
(c) concentrating the solution obtained by ultrafiltration, optionally with diafiltration to form an MPI or MPC having at least 70% dry weight as protein and
(d) drying to prepare a dried product with enhanced solubility.
3. A method of preparing a dried enhanced-solubility MPC or MPI comprising:
(a) providing a skim milk solution in the form of an aqueous solution/suspension; (b) concentrating the skim milk by ultrafiltration, with diafiltration, to form an
MPI or MPC having at least 70% dried weight as protein; (c) drying to prepare a dried product with enhanced solubility;
wherein the diafiltration medium comprises at least one monovalent salt.
4. A method for preparing a dried enhanced-solubility MPC or MPI comprising:
(a) providing an MPI or MPC having at least 70% dry matter as milk protein in aqueous solution/suspension;
(b) removing part of the water from the MPC or MPI; (c) adding to the concentrated MPC or MPI at least one monovalent salt in an amount that confers enhanced solubility on the product; (d) drying the product.
5. A method as claimed in claim 4 wherein the dewatering step is an evaporation step.
6. A method as claimed in claim 7 wherein the salt is a potassium or sodium salt.
7. A method as claimed in claim 8 wherein the salt is sodium chloride.
8. A method as claimed in any one of claims 1-8 wherein at least one divalent salt is added prior to the drying step.
9. A method as claimed in claim 9 wherein the divalent salt is a calcium salt.
10. A method as claimed in any one of claims 1-9 wherein 0.013-0.30 moles of cation is added per lOOg protein.
11. Amethod as claimed in claim 10 wherein 0.035-0.25 moles of cation is added per lOOg protein.
12. A method as claimed in claim 11 wherein 0.035-0.10 moles of cation is added per lOOg protein.
13. A method as claimed in claim 1 or claim 4 wherein the MPI or MPC in aqueous solution/suspension is formed by reconstituting a dried MPI or MPC at a temperature sufficient to solubihse it.
14. A dried enhanced-solubility MPC or MPI produced by a method as claimed in any one of claims 1-13.
15. A dried MPC or MPI having at least 70% dried weight as protein comprising 0.013-0.30 moles of added cation per lOOg protein.
16. A method of cheese manufacture wherein the milk starting material is extended with a dried MPC as claimed in claim 14 or 15.
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NZ512098 | 2001-05-31 | ||
| NZ512098A NZ512098A (en) | 2001-05-31 | 2001-05-31 | Addition of monovalent or divalent salts to enhance solubility of a dried milk protein concentrate and its use in cheese manufacture |
| NZ512281 | 2001-06-08 | ||
| NZ51228101 | 2001-06-08 | ||
| PCT/NZ2002/000105 WO2002096208A2 (en) | 2001-05-31 | 2002-05-31 | Monovalent salt enhances solubility of milk protein concentrate |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2002344204A1 true AU2002344204A1 (en) | 2003-05-08 |
| AU2002344204B2 AU2002344204B2 (en) | 2008-07-31 |
Family
ID=26652257
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2002344204A Ceased AU2002344204B2 (en) | 2001-05-31 | 2002-05-31 | Monovalent salt enhances solubility of milk protein concentrate |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20040208955A1 (en) |
| EP (1) | EP1553843B1 (en) |
| JP (1) | JP2005506055A (en) |
| AT (1) | ATE362319T1 (en) |
| AU (1) | AU2002344204B2 (en) |
| CA (1) | CA2448929A1 (en) |
| DE (1) | DE60220193T2 (en) |
| ES (1) | ES2287317T3 (en) |
| WO (1) | WO2002096208A2 (en) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3833129B2 (en) * | 2002-03-19 | 2006-10-11 | 株式会社Adeka | Concentrated milky composition |
| US8080276B2 (en) | 2002-08-23 | 2011-12-20 | Fonterra Co-Operative Group Ltd. | Method for producing a food product from a concentrated protein |
| US20060159804A1 (en) * | 2002-12-24 | 2006-07-20 | Bhaskar Ganugapati V | Dairy protein process and applications thereof |
| US7220442B2 (en) | 2003-02-20 | 2007-05-22 | Slim-Fast Foods Company, Division Of Conopco, Inc. | Nutrition bar and process of making components |
| WO2007026474A1 (en) | 2005-08-29 | 2007-03-08 | Ajinomoto Co., Inc. | Nutrient composition |
| NZ549470A (en) * | 2006-08-28 | 2009-01-31 | Fonterra Co Operative Group | Dairy product and process |
| US9232808B2 (en) | 2007-06-29 | 2016-01-12 | Kraft Foods Group Brands Llc | Processed cheese without emulsifying salts |
| CN102630802A (en) * | 2012-05-15 | 2012-08-15 | 东北农业大学 | Cow milk protein concentrates with high water-holding capability and preparation method thereof |
| CN104904989B (en) * | 2015-07-06 | 2019-01-08 | 光明乳业股份有限公司 | Milk protein concentrate of high thermal stability and preparation method thereof |
| US20180228197A1 (en) | 2015-08-07 | 2018-08-16 | Tamarack Biotics Llc | Methods for production of an immune-active milk product and uses thereof |
| RU2673903C2 (en) * | 2016-12-13 | 2018-12-03 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Восточно-Сибирский государственный университет технологий и управления" | Method of calcium containing dairy-protein concentrate producing |
| CN106902657A (en) * | 2017-02-23 | 2017-06-30 | 安徽顺和生物科技有限公司 | Uniform method is sufficiently mixed during a kind of infant's diatery supplement dispensing |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5128156A (en) * | 1990-11-21 | 1992-07-07 | Borden, Inc. | Process for preparing an alternate protein source for coffee whiteners and other products |
| WO2000051440A1 (en) * | 1999-03-01 | 2000-09-08 | New Zealand Dairy Board | Membrane filtered milk proteins varying in composition and functional attributes |
-
2002
- 2002-05-31 AU AU2002344204A patent/AU2002344204B2/en not_active Ceased
- 2002-05-31 EP EP02774083A patent/EP1553843B1/en not_active Expired - Lifetime
- 2002-05-31 WO PCT/NZ2002/000105 patent/WO2002096208A2/en not_active Ceased
- 2002-05-31 ES ES02774083T patent/ES2287317T3/en not_active Expired - Lifetime
- 2002-05-31 DE DE60220193T patent/DE60220193T2/en not_active Expired - Fee Related
- 2002-05-31 CA CA002448929A patent/CA2448929A1/en not_active Abandoned
- 2002-05-31 AT AT02774083T patent/ATE362319T1/en not_active IP Right Cessation
- 2002-05-31 US US10/479,401 patent/US20040208955A1/en not_active Abandoned
- 2002-05-31 JP JP2002592730A patent/JP2005506055A/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US7157108B2 (en) | Milk protein products and processes | |
| AU2002338661B2 (en) | Modified milk protein concentrates and their use in making gels and dairy products | |
| US20080305235A1 (en) | Whey Product and Process | |
| AU2003288836B2 (en) | Dairy protein process and applications thereof | |
| AU2002344204B2 (en) | Monovalent salt enhances solubility of milk protein concentrate | |
| HUT77043A (en) | Physical separation of casein and whey proteins | |
| AU2002338661A1 (en) | Modified milk protein concentrates and their use in making gels and dairy products | |
| AU2002344204A1 (en) | Monovalent salt enhances solubility of milk protein concentrate | |
| NZ527159A (en) | Dairy product and process | |
| JP3210333B2 (en) | Instantaneous thermal flocculation by adjusting the alkali metal ion content of proteins which can be flocculated at isoelectric pH, such as casein, coagulates thus obtained and their use, especially for the production of foodstuffs | |
| MXPA06001282A (en) | Production of protein composition from a dairy stream and its use as an ingredient in the manufacture of a cheese. | |
| AU2007336286A1 (en) | A method for producing cheese | |
| EP0427307B1 (en) | Dairy products | |
| NZ512098A (en) | Addition of monovalent or divalent salts to enhance solubility of a dried milk protein concentrate and its use in cheese manufacture | |
| Singh | Protein interactions and functionality of milk protein products | |
| DE DK et al. | EINWERTIGES SALZ VERBESSERT DIE LÖSLICHKEIT VON MILCHPROTEINKONZENTRAT SEL MONOVALENT AMELIORANT LA SOLUBILITE D’UN CONCENTRE DE PROTEINE DE LAIT | |
| SU1664238A1 (en) | Composition for koumiss and method for it preparation |